Navigation Links
Entegrion Announces Organizational Changes to Support Advanced Product Development
Date:6/19/2013

Research Triangle Park, NC (PRWEB) June 19, 2013

North Carolina-based life sciences company Entegrion, Inc., announced organizational changes to advance development of its technologies.

Entegrion’s Executive Chairman John B. Mowell said, “To support the advanced development of our product candidates Entegrion’s Board of Directors has made changes to the Company’s management structure and engaged industry leaders as key advisors.”

The Company announced that Michael Galiger will serve as Vice President of Operations with primary responsibility for development of Entegrion’s plasma product Resusix, as well as supporting the continued advancement of the Company’s other technologies. “Mike’s technical background, intensive work with the development of Entegrion’s products, and his success in attracting a solid product development team, including Stacy Hammonds as Director of Clinical Operations, and Taegen Sullivan, Product Development Engineer, have made a substantial contribution to Entegrion’s success,” Mowell continued.

Entegrion also announced the formation of a clinical advisory Board initially comprised of Paul Ness, MD, Director of Transfusion Medicine at Johns Hopkins; Professor Peter Rhee, MD, Chief of Trauma, Critical Care, Burns and Emergency Surgery, University of Arizona; Edward Scott, MD, President of Key Biologics; and Philip C. Spinella, MD, Director, Pediatric Critical Care Translational Research Program, Washington University, St. Louis.

“We are immensely proud to be associated with these world-class leaders in transfusion and trauma medicine. Drs. Rhee and Spinella both came out of the Armed Forces and served in Iraq. They will bring a unique ‘user perspective’ to our technologies. Dr. Scott has decades of experience with the supply of blood and blood derivatives, and Dr. Ness is an expert in transfusion medicine. Their guidance will be invaluable as our biologic and medical device technologies move into advanced development,” Mowell said.

Entegrion also announced that Richard Martin will serve as Executive Vice President with responsibility for Entegrion’s overall day-to-day business operations reporting to the Executive Chairman, and will assist in the areas of strategic corporate planning and development. Susan Reyer, the Company’s Controller for the past five years, now serves as Vice President, Chief Financial Officer, with responsibility for the Company’s financial and administrative matters.

Joseph DaCorta will continue in his role as Chief Technology Officer, with responsibility for managing Entegrion’s government relations and exploring new opportunities to utilize the Company’s technologies. Arthur Bode continues to serve as Vice President, Chief Science Officer in charge of scientific research and project support.

Mowell stated, “We are fortunate that each of the senior members of our management team have been integral to the company’s operations for a number of years, positioning Entegrion well for continued success.”

Over the past three years, Entegrion has announced Department of Defense contract awards totaling more than $50 million for the development of resuscitation and coagulation technologies that have important healthcare applications for US Armed Forces.

About Entegrion
Entegrion, Inc. is a life sciences product development company that is focused on improving the safety and availability of the world’s blood supply. Based in North Carolina’s Research Triangle Park, Entegrion offers patented technologies designed to overcome limitations in storage, safety, and availability of blood-derived products while preserving their functionality. Many of Entegrion’s advances in biologics are based on close collaborations with leading medical research institutions. Visit http://www.entegrion.com for more information.

Read the full story at http://www.prweb.com/releases/2013EntegrionLeadership/06Updates/prweb10848250.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Bird-B-Gone Inc.® Announces Launch of Pond Defender™
2. Viewpoints TV Announces June Air Dates for Phoenix, AZ
3. Arem Wellness Announces a Recipe Contest
4. CoachingWebsites (Websites for Coaches) Announces Their Partnership With Active Intelligence, LLC
5. MinuteHound Announces How Cloud Computing Technology Boosts Savings
6. Internationally Acclaimed Breast Augmentation Expert Announces the Launch of His New Website
7. hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces Improved hCG Diet Plans, Fast Weight Loss Now Thought to Decrease Risk of Heart Disease
8. Vet Supply Source Announces Sweepstakes Contest Winner
9. VegasHotelEscapes Announces Special Hotel Packages For Dash Berlin At The Lavo
10. Tarrant Plastic Surgery Announces Summer Makeover Special
11. Rottenstein Law Group LLP Announces New Tylenol Lawsuit Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... The Karen Miller Agency, a ... in the greater Birmingham area, is joining the Chris Hammond Youth Foundation in ... the region. , The Chris Hammond Youth Foundation maintains athletic facilities in rural ...
(Date:7/21/2017)... ... July 21, 2017 , ... Fresh Wave® IAQ today announced ... odor-control solution for colleges and universities at the APPA 2017 Annual Conference ... cannabis and tobacco smoke odors without the use of harsh chemicals, Fresh Wave IAQ ...
(Date:7/21/2017)... ... , ... Hospital M&A activity slowed in the second quarter of 2017, according ... to 23 in the second quarter, up 15% from the 20 publicly announced acquisitions ... in the year-ago second quarter. Only four of the transactions disclosed a purchase price ...
(Date:7/21/2017)... ... 2017 , ... The Margarian Law Firm has filed a class action ... for allegedly containing no ginger. Dr. Pepper produces the “Canada Dry” brand of ginger ... alleges Canada Dry Ginger Ale claims on its bottle that it is made from ...
(Date:7/21/2017)... ... 21, 2017 , ... The Visiting Nurse Association of ... R. Bard Foundation, Inc. to support the music therapy program offered at ... the nonprofit home care agency. Using evidence-based methods, professionally trained and certified music ...
Breaking Medicine News(10 mins):
(Date:7/14/2017)... 13, 2017 It should come as no surprise ... is in the midst of a crippling opioid epidemic. According ... the number of overdose deaths from opiate-based medications has quadrupled, ... a million dead from 2001 to 2015". During this time, ... has similarly quadrupled, drawing a compelling link between prescription and ...
(Date:7/12/2017)... INDIANAPOLIS , July 12, 2017  Eli Lilly and ... settlement agreement with generic companies to resolve pending patent litigation ... Virginia regarding the Cialis ® ... expire on April 26, 2020. As part of the agreement, ... on September 27, 2018. "The unit dose patent ...
(Date:7/11/2017)... 11, 2017  Dr. Echenberg, founder of Echenberg Institute, is announcing a ... who suffer from painful intercourse and other painful pelvic pain conditions such ... to menopause. ... LLC ... Sarasota, Florida -based start-up company, VuVatech LLC, fills a void ...
Breaking Medicine Technology: